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In 2003, Herridge et al (1) first described poor functional outcomes in working-age, 1-year survivors of acute respi-ratory distress syndrome (ARDS). In the ensuring decade, 
countless studies have confirmed that poor long-term out-
comes are the rule, not the exception, after ARDS. Survivor-
ship from critical illness has been heralded as the defining 
challenge of critical care in the 21st century (2). Recently, help-
ing patients to thrive after critical illness was deemed the “third 
revolution” of critical care (3).
As the field of critical care medicine increasingly focuses on 
long-term outcomes, it is important to recognize that long-term 
outcomes are the result of two distinct components: early and 
late events (Fig. 1). For example, 5-year mortality is the result of 
early mortality (e.g., in-hospital death) and late mortality (e.g., 
death after hospital discharge but within 5 yr of hospitaliza-
tion). If early mortality is sufficiently high enough, then long-
term mortality will be high even if the critical illness does not 
increase risk for late death among those who survive to hospital 
discharge. When considering long-term mortality from critical 
illness, it is important to differentiate between early and late 
deaths because they are driven by different  factors (4).
While early mortality from ARDS has been steadily declin-
ing with time (5), late mortality—death in the years after ARDS 
hospitalization—remains high (6). Drivers of this late mortal-
ity are not well understood. As would be expected, age, preex-
isting chronic medical conditions, and prior nursing home use 
predict increased risk for late mortality (6). As yet, though, we 
have not elucidated if or how ARDS itself increases risk for late 
mortality relative to age and comorbidity-matched controls.
In studies with careful matching and control for confound-
ing, pneumonia (7), sepsis (8), and all-cause critical illness (9) 
have each been found to increase survivor’s risk for late mortal-
ity, independent of age, and baseline health status. So, we can 
reasonably hypothesize that surviving ARDS also increases one’s 
risk for late mortality. But, the mechanisms by which any of these 
acute diseases increases late mortality remain poorly understood. 
Impaired immunity, weakness, accelerated cardiovascular dis-
ease, or heightened risk for malignancy may all play a role.
In this issue of Critical Care Medicine, Dinglas et al (10) 
examined the relationship of skeletal muscle weakness and 
late mortality in ARDS survivors—in effect, tying together 
outcomes which are often considered in isolation: functional 
disability and late mortality. Skeletal muscle wasting occurs 
rapidly in critical illness, is a major contributor to functional 
disability (11), and predicts early mortality (12). But, the 
impact of muscle weakness on late mortality in ARDS survi-
vors has not been described previously.
One hundred fifty-six ARDS survivors were followed to death 
or for 5 years following hospital discharge. Muscle strength was 
measured at hospital discharge and again 3, 6, 12, 24, 36, and 
48 months postdischarge using the Medical Research Council 
(MRC) sum score, a 0 to 60 strength scale where a score less 
than 48 is considered to reflect pathologic weakness. The MRC 
is recommended by several critical care professional societies to 
measure muscle strength but is a subjective test (13). To combat 
the known subjectivity of MRC, this study included rigorous 
quality control; strength assessors underwent initial training 
and periodic quality review for the duration of the study to 
ensure high interrater reliability of their assessments.
The authors examined the association of weakness at hos-
pital discharge and changes in weakness over time (persistent, 
resolved, and new) with 5-year mortality. An initial multivariable 
model was used to inform a parsimonious set of covariates (age, 
comorbidity, and mean daily Sequential Organ Failure Assess-
ment score) that were included in the final Cox proportional haz-
ard model. Each of these covariates been previously described to 
affect either skeletal muscle loss/function (14) or mortality (15).
At hospital discharge, 38% of the ARDS survivors in this 
study had muscle weakness, and one third of the cohort died 
during the 5-year follow-up period. Muscle weakness at hospital 
discharge was independently associated with 5-year mortality. 
The association persisted whether weakness was considered as 
a binary predictor (being weak at hospital discharge predicted 
5-yr mortality) or as a continuous predictor (each additional 
one point loss of strength predicted higher 5-yr mortality).
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Persistent weakness (maintaining MRC < 48) over time was 
associated with worse 5-year survival, compared with main-
taining a normal MRC. But curiously, resolving weakness was 
no better than persistent weakness, suggesting that weakness 
at hospital discharge is an ominous sign, even if a patient is 
subsequently able to rehabilitate back to normal strength. In 
future work, it would be interesting to see the relationship 
of muscle weakness trajectories to late mortality stratified 
by physical function at hospital discharge (16) or inflamma-
tory load during acute illness (17). Progressing from normal 
strength to weakness during the 5-year follow-up period was 
not associated with worse 5-year survival, but this trajectory 
had insufficient power to draw strong conclusions.
These data attractively suggest that muscle wasting is a uni-
fying contributor to late mortality and functional disability. An 
alternative view may be that muscle weakness and weakness 
trajectories are epiphenomena of the more holistic concept 
of frailty (18), and that frailty drives late mortality. Yet, it is 
biologically plausible that muscle weakness itself increases late 
mortality. Muscle weakness may cause swallowing dysfunction 
(19), decreased nutritional intake (19), increased aspiration 
(19), and decreased physical activity (20), which in turn may 
increase the risk for cardiovascular events and malignancy. 
Individually or in combination, these factors may impair mus-
cle protein synthesis, leading to a vicious cycle of maintained 
cachexia—which is strongly associated with mortality (21).
As in-hospital mortality from ARDS continues to fall, we 
are increasingly challenged to improve the survivor experi-
ence. This study argues that skeletal muscle weakness is a key 
determinant of not only functional disability but also of late 
mortality. Even those patients whose weakness improved over 
time experienced increased rates of 5-year mortality, under-
scoring the importance of preventing muscle loss during the 
acute phase of critical illness.
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